JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

Benzinga Newsdesk www.benzinga.com Positive 59.8%

Neg 0% Neu 0% Pos 59.8%

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.